Biofarm

Crosspoint Real Estate, international partner of Savills in Romania, has assisted the pharmaceutical company Biofarm in a significant transaction. The deal, worth approximately EUR 5 million, involved the sale of a strategic property in the…

Biofarm, one of Romania's leading drug manufacturers, has continued to invest in its production and testing facility inaugurated last year in Bucharest, so that it has already reached 44 million euros, after generating a total of 35 million…

Biofarm, one of Romania's drug manufacturers, reports significant increases for the first nine months of the year compared to the same period in 2020. Biofarm recorded a turnover of lei 179 million in the first nine months of 2021 and a net…

Biofarm, one of the most important drug manufacturers in Romania, inaugurated a new production and testing facility in Bucharest, in which over 35 million euros were invested. With a usable area of over 10.000 sqm and an annual…

The Romanian Investor Relations Association has announced that Biofarm had become Associate Member of ARIR. Biofarm is one of the first drug manufactures in Romania, founded 100 years ago by merging several pharmaceutical companies. Biofarm…